A detailed history of Victory Capital Management Inc transactions in Ardelyx, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 28,780 shares of ARDX stock, worth $158,865. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,780
Previous 29,089 1.06%
Holding current value
$158,865
Previous $215,000 7.91%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$5.28 - $7.57 $1,631 - $2,339
-309 Reduced 1.06%
28,780 $198,000
Q2 2024

Aug 05, 2024

SELL
$5.89 - $9.31 $194,917 - $308,095
-33,093 Reduced 53.22%
29,089 $215,000
Q1 2024

May 03, 2024

BUY
$6.05 - $9.74 $194,096 - $312,478
32,082 Added 106.58%
62,182 $453,000
Q4 2023

Feb 05, 2024

BUY
$3.29 - $6.64 $23,414 - $47,256
7,117 Added 30.97%
30,100 $186,000
Q3 2023

Nov 06, 2023

BUY
$3.3 - $4.83 $6,963 - $10,191
2,110 Added 10.11%
22,983 $93,000
Q2 2023

Jul 27, 2023

SELL
$3.23 - $4.95 $977,385 - $1.5 Million
-302,596 Reduced 93.55%
20,873 $70,000
Q1 2023

May 02, 2023

BUY
$2.68 - $4.79 $22,016 - $39,349
8,215 Added 2.61%
323,469 $1.55 Million
Q4 2022

Feb 09, 2023

BUY
$1.22 - $2.85 $4,354 - $10,171
3,569 Added 1.15%
315,254 $898,000
Q3 2022

Nov 02, 2022

SELL
$0.59 - $1.44 $4,653 - $11,357
-7,887 Reduced 2.47%
311,685 $371,000
Q2 2022

Aug 01, 2022

BUY
$0.51 - $1.17 $890 - $2,043
1,747 Added 0.55%
319,572 $188,000
Q1 2022

May 04, 2022

SELL
$0.65 - $1.18 $4,262 - $7,738
-6,558 Reduced 2.02%
317,825 $336,000
Q4 2021

Feb 07, 2022

BUY
$0.86 - $1.7 $268,194 - $530,151
311,854 Added 2489.06%
324,383 $357,000
Q3 2021

Nov 02, 2021

SELL
$1.27 - $8.17 $88 - $571
-70 Reduced 0.56%
12,529 $17,000
Q2 2021

Aug 03, 2021

SELL
$6.55 - $8.98 $406 - $556
-62 Reduced 0.49%
12,599 $96,000
Q1 2021

May 04, 2021

BUY
$6.1 - $7.69 $4,373 - $5,513
717 Added 6.0%
12,661 $84,000
Q4 2020

Feb 01, 2021

BUY
$5.05 - $7.1 $3,782 - $5,317
749 Added 6.69%
11,944 $77,000
Q3 2020

Nov 09, 2020

SELL
$5.25 - $7.08 $1,758 - $2,371
-335 Reduced 2.91%
11,195 $59,000
Q2 2020

Aug 07, 2020

SELL
$5.37 - $8.11 $2,309 - $3,487
-430 Reduced 3.6%
11,530 $80,000
Q1 2020

May 04, 2020

BUY
$4.35 - $8.79 $10,496 - $21,210
2,413 Added 25.27%
11,960 $68,000
Q4 2019

Feb 04, 2020

BUY
$4.23 - $8.29 $7,009 - $13,736
1,657 Added 21.0%
9,547 $68,000
Q3 2019

Nov 12, 2019

BUY
$2.15 - $6.28 $16,963 - $49,549
7,890 New
7,890 $37,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $854M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.